✦ LIBER ✦

Stereoselective pharmacokinetics of bisoprolol after intravenous and oral administration in beagle dogs

✍ Scribed by Yuji Horikiri; Takehiko Suzuki; Masakazu Mizobe

Book ID: 109388740
Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 196 KB
Volume: 86
Category: Article
ISSN: 0022-3549
DOI: 10.1021/js960453v

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of forsythoside after i

Pharmacokinetics of forsythoside after intravenous administration in beagle dogs

✍ Rong Shi; Zhenyu Xuan; Yueming Ma; Yingying Liu; Hongguo Lu; Tianjiang Sun 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 640 KB

Multiple oral dosing of ketoconazole inf

Multiple oral dosing of ketoconazole influences pharmacokinetics of quinidine after intravenous and oral administration in beagle dogs

✍ M. Kuroha; Y. Shirai; M. Shimoda 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Pharmacokinetics of fostedil, a new calc

Pharmacokinetics of fostedil, a new calcium antagonist, in beagle dogs following oral and intravenous administration

✍ Elizabeth W. Thomas; Barbara A. Bopp 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB

Comparison of the pharmacokinetics of mo

Comparison of the pharmacokinetics of moxidectin and ivermectin after oral administration to beagle dogs

✍ Sayer I. Al-Azzam; Lawrence Fleckenstein; Kuei-Ju Cheng; Michael T. Dzimianski; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

Stereoselective pharmacokinetics of meth

Stereoselective pharmacokinetics of methadone in beagle dogs

✍ Norbert Schmidt; Kay Brune; Kenneth M. Williams; Dr. Gerd Geisslinger 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB 👁 1 views

Pharmacokinetics of ftorafur after intra

Pharmacokinetics of ftorafur after intravenous and oral administration

✍ Markku I. Anttila; Eero A. Sotaniemi; Matti I. Kairaluoma; Risto E. Mokka; Hannu 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 363 KB

The pharmacokinetics of ftorafur (FT), an antineoplastic agent, has been studied in seven cancer patients by determining concentrations of the unchanged compound in serum after single IV and PO doses of 2 g FT. Serum drug concentrations were determined by a new quantitative thin-layer chromatographi